Cord Blood. Investieren in die Zukunft von Morgen.

http://www.finanznachrichten.de/...-statement-to-shareholders-008.htm

http://www.finanznachrichten.de/...rs-on-laboratory-licensing-008.htm  

Art gibt es ja immer wieder welche, bis jetzt hatte aber keine den Kurs irgendwie nachhaltig nach vorn gebracht, daher bin ich auch weiterhin sehr skeptisch.  

universalbloodtypes.com/cord-blood-bank-america-will-now-offer-stem-cell-collection-services/

 

sollte man die Todesstrafe verpassen  

 

on Argentina

LAS VEGAS and BUENOS AIRES, Argentina, Sept. 27, 2011 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today updated shareholders on the progress of Biocordcell Argentina S.A. (BioCells, Inc.), which is 50.1 percent owned by Cord Blood America.

"January through August revenues in 2011 are up 40 percent to $1.18 million (U.S.)," said Diego Rissola, president of BioCells, Inc. "The increase in revenues reflects the fact that we have established franchises in six provinces in Argentina and we opened an office in Miami, Florida, to service the Latin American population there. We are now signing 11 percent more new contracts than we did in the same period in 2010."

"We have been successful with e-marketing, using a new web page and social media. We also now have operations in Brazil and the Dominican Republic, and the development of storing dental pulp is proving to be a potential revenue enhancer for the Company," Mr. Rissola said.

"BioCells of Argentina has performed fantastically in a down global economy. We''ve realized great growth, profitability, just a good story all around. We''re fortunate to have purchased the control position of this ever expanding company," said Matthew Schissler, CEO of Cord Blood America.

(Revenue and other financial estimates contained in this press release have not been audited or reviewed by Cord Blood America''s independent auditors. The Company provides no assurance that these preliminary results will not change following the completion of its financial audit for Fiscal 2011.)

http://www.finanznachrichten.de/...-shareholders-on-argentina-008.htm

Ich hoffe das das endlich mal was bringt.Es wird Zeit das hier endlich mal die kasse klingelt und wir den Aufschwung sehen ,ansonsten sehe ich schwarz.  

We get occasional questions about our partnership in China. China Stem Cell, Ltd. now has both private customers and donated stem cells stored at its facility. The Company has already provided stem cells for a transplant operation and has contracts signed with hospitals in China. Because of the one child policy in that nation, and the reverence with which parents hold that one child, the Chinese appear to be storing stem cells at rates greater than in the U.S. and Europe.  

zu haben.
Es hat mich einiges Geld gekostet, diese Erkenntnis zu erlangen.
Genta, Cord Blood...

Indikatoren:
- Finanzierungsmodellen über Aktienzuteilungen
- Reverse Splits
- keine signifikanten Erfolge
- hochtrabende Presseerklärungen
- Finanzierungsmodellen über Aktienzuteilungen
- Reverse Splits
- keine signifikanten Erfolge
- hochtrabende Presseerklärungen
- Finanzierungsmodellen über Aktienzuteilungen
- Reverse Splits
- keine signifikanten Erfolge
- hochtrabende Presseerklärungen

> Copy und Paste Problem?
Nein, das ist der Teufelskreislauf!  

verlassen das sinkende schiffchen  

viele kapitalerhöhungen müssen die hinter sich haben um jetzt schon aus über 5 mrd. aktien zu bestehen? ;-))  

Dieser Drecksau müsste man die Todesstrafe wegen Betruges verpassen.  

Das diese Masche immer noch funktioniert finde ich am erstaunlichsten.  

ich weiß auch nicht wie die das machen
vllt teilen die sich die selbst aus  

Cord Blood America, Inc. to Evaluate Possible Strategic Alternatives

LAS VEGAS, Oct. 12, 2011 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord bloodstem cell preservation companyfocused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced that its Board of Directors will conduct a process to explore and evaluate strategic alternatives for Cord Blood America to enhance shareholder value.

Cord Blood America has not set a timetable for completion of the evaluation process or made a decision to pursue any particular transaction or other alternative, and there can be no assurancethat any transaction or other alternative will be pursued or completed.

Cord Blood America does not intend to comment further regarding the evaluation of possible strategic alternatives, unless a specific transaction or process is concluded, or it otherwise deems further disclosure is appropriate or required.

About Cord Blood America

Cord Blood America is the parent company of CorCell, Companies, Inc., which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc., visit our website at http://www.corcell.com/. For investor information, visithttp://www.cordblood-america.com/.

CONTACT: Paul Knopick
E & E Communications
(949) 707-5365
pknopick@eandecommunications.com

Forward-Looking Statements

Some statements made in this press release are forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as "anticipate," "believe," "expect,'' "future," "intend," "plan," and similar expressions to identify forward-looking statements. These statements including those related to the growth of the industry, new stem cell treatments, and the Cord Blood America''s performance, are only predictions and are subject to certain risks, uncertainties and assumptions. Additional risks are identified and described in the Company''s public filings with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company''s past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.

SOURCE Cord Blood America, Inc.

© 2011 PR Newswire  

Und daraus soll man schlau werden?  

kostet mich ja mehr die drecksscheine loszuwerden als sie noch wert sind sowas nennt man wohl totes investment und liegen in meinem depot bis ich sterbe, wenn sie nicht vorher gestrichen werden!

 

kostet mich ja mehr die drecksscheine loszuwerden als sie noch wert sind sowas nennt man wohl totes investment und liegen in meinem depot bis ich sterbe, wenn sie nicht vorher gestrichen werden!

 

denke mal die werden in kürze gestrichen
irgendwas scheint da nicht zu stimmen  

passiert nach den Erfahrungen der dotcom Blase, tztz  ;-))  

www.finanzen.net/nachricht/aktien/...n-vom-Urteil-profitieren-1429545

 

 

 

Habe mir mal 'ne Position gegönnt nach dem Rücksetzer.Zeigt sich stabil,könnte durchaus weiter nach oben laufen(siehe Chart).Realtime Bid&aAsk0,032-0,034.GLTA